Ep2 Antagonist

Patent No. EP3992176 (titled "Ep2 Antagonist") was filed by ONO Pharmaceutical on Jun 26, 2020. The application was issued on Aug 27, 2025.

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Sep 9, 2025
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Jul 31, 2025
Decision to grant a European patent
Jul 23, 2025
(Electronic) Receipt
Jul 23, 2025
French translation of claims
Jul 23, 2025
German translation of the claims
Jul 23, 2025
Letter accompanying subsequently filed items
Mar 24, 2025
Bibliographic data of the European patent application
Mar 24, 2025
Communication about intention to grant a European patent
Mar 24, 2025
Intention to grant (signatures)
Mar 24, 2025
Text intended for grant (clean copy)
Mar 24, 2025
Text intended for grant (version for approval)
Feb 14, 2025
(Electronic) Receipt
Feb 14, 2025
Amended claims with annotations
Feb 14, 2025
Claims
Feb 14, 2025
Description
Feb 14, 2025
Letter accompanying subsequently filed items
Feb 14, 2025
Request for correction/amendment of the text proposed for grant sent from 01.04.2012
Oct 17, 2024
Annex to the communication about intention to grant a European patent
Oct 17, 2024
Bibliographic data of the European patent application
Oct 17, 2024
Communication about intention to grant a European patent
Oct 17, 2024
Intention to grant (signatures)
Oct 17, 2024
Text intended for grant (clean copy)
Oct 17, 2024
Text intended for grant (version for approval)
Sep 26, 2024
Examination started
Feb 17, 2023
(Electronic) Receipt
Feb 17, 2023
Amended claims filed after receipt of (European) search report
Feb 17, 2023
Amended claims filed after receipt of (European) search report
Feb 17, 2023
Amended claims with annotations
Feb 17, 2023
Amended claims with annotations
Feb 17, 2023
Amendments received before examination
Feb 17, 2023
Letter accompanying subsequently filed items
Feb 17, 2023
Non-patent literature cited during the examination procedure
Aug 9, 2022
Invitation to declare maintenance of the application and to correct deficiencies in the Written Opinion/amend application
Jul 21, 2022
Communication regarding the transmission of the European search report
Jul 21, 2022
European search opinion
Jul 21, 2022
Information on Search Strategy
Jul 21, 2022
Supplementary European search report
Jul 11, 2022
Search started
Apr 6, 2022
Notification of forthcoming publication
Jan 10, 2022
Copy of the international preliminary report on patentability
Jan 10, 2022
Translation of the international preliminary report on patentability
Dec 22, 2021
(Electronic) Receipt
Dec 22, 2021
Abstract
Dec 22, 2021
Amended claims filed after receipt of (European) search report
Dec 22, 2021
Amended description filed after receipt of (European) search report
Dec 22, 2021
Annex
Dec 22, 2021
Claims
Dec 22, 2021
Description
Dec 22, 2021
Drawings
Dec 22, 2021
Request for entry into the European phase
Nov 5, 2021
Information on entry into European phase
Oct 15, 2021
Notification of the recording of a change
Jan 18, 2021
Priority document (electronically transmitted)
Dec 30, 2020
Copy of the international search report
Dec 30, 2020
Copy of the translated international search report
Dec 30, 2020
International publication pamphlet

EP3992176

ONO PHARMACEUTICAL

Application Number: EP20832376A
Filing Date: Jun 26, 2020
Status: Granted And Under Opposition; Jul 25, 2025
Publication Date: Aug 27, 2025
External Links: Slate, Register , Google Patents

IP Verse

Ep2 Antagonist

Patent Summary

Patent Family

Dossier Documents

EP3992176